Cognitive function, dementia and type 2 diabetes mellitus in the elderly (Q37832122)

24 August 2017

1 reference

title

Cognitive function, dementia and type 2 diabetes mellitus in the elderly (English)

1 reference

24 August 2017

0 references

0 references

Rebecca M Reynolds

2

0 references

Riccardo E Marioni

object named as

Riccardo E Marioni

series ordinal

3

0 references

author name string

Mark W J Strachan

series ordinal

1

1 reference

24 August 2017

Jacqueline F Price

series ordinal

4

1 reference

24 August 2017

language of work or name

1 reference

1 February 2011

1 reference

Nature Reviews Endocrinology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

108-114

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Low dose aspirin and cognitive function in the women's health study cognitive cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Long-term effect of diabetes and its treatment on cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Retinal microvascular abnormalities and cognitive dysfunction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Severe hypoglycaemia and cognitive impairment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Blood-brain barrier transport of cytokines: a mechanism for neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Inflammation and rate of cognitive change in high-functioning older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Systemic markers of inflammation and cognitive decline in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Contribution of metabolic syndrome components to cognition in older individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The metabolic syndrome, inflammation, and risk of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cognitive function and blood rheology: results from the Caerphilly cohort of older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Haemostasis in ischaemic stroke and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Stress and the aging hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Hippocampal aging and adrenocorticoids: quantitative correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Brain Aging Correlates: Retardation by Hormonal-Pharmacological Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The stress system in the human brain in depression and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Salivary cortisol day profiles in elderly with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Plasma cortisol levels, brain volumes and cognition in healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Age changes in processing speed as a leading indicator of cognitive aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The Edinburgh Type 2 Diabetes Study: study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The interaction of depression and diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The glucocorticoid receptor: part of the solution or part of the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Glucocorticoid receptor polymorphisms in major depression. Focus on glucocorticoid sensitivity and neurocognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Depressive symptoms, race, and glucose concentrations: the role of cortisol as mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Statins for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Is sticky blood a treatable determinant of cognitive decline and of dementia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Hypercortisolism in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Cortisol Secretion in Patients With Type 2 Diabetes: Relationship with chronic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Glucocorticoids, cytokines and brain abnormalities in depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Subtle and obvious keys for the Minnesota multiphasic personality inventory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.228

Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21263438

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2010.228

1 reference

24 August 2017

1 reference